Work

551P SHR-A1811 combined with adebrelimab in HR-/HR-low, HER2-low metastatic breast cancer: Preliminary results from an open-label, single-arm, phase II trial

Year: 2025

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2025.08.974

Authors: J. Liu, M. Jiang, D. Sang, M. Zhang, S. Zhou, M. Li, F. Zhang, L. Qin, J. Li, Y. Zhang, F. Ma, B. Xu, Q. Li

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Cancer Hospital of Huanxing Chaoyang District Beijing, Jiangsu Hengrui Medicine (China)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Key Research and Development Program of China

Award: G3372219949

OpenAlex ID: W4415940233

FWCI:

Cites:

Cited by:

Related to: